Editorial: Combining Forces to Improve Alzheimer's Disease Drug Discovery: The Symptomatic Battle
CNS Neurol Disord Drug Targets
.
2016;15(7):754-5.
doi: 10.2174/187152731507160808200737.
Authors
Julie Deguil
,
Alexandra Auffret
,
Esther Schenker
,
Fabienne Aujard
,
Yves Lamberty
,
David Bartrès-Faz
,
Olivier Blin
,
Joëlle Micallef
,
Jill C Richardson
,
Régis Bordet
1
Affiliation
1
Department of Pharmacology, University Lille Nord de France, Lille, France. regis.bordet@univ-lille2.fr.
PMID:
27549167
DOI:
10.2174/187152731507160808200737
No abstract available
Publication types
Review
MeSH terms
Academic Medical Centers
Alzheimer Disease / drug therapy*
Alzheimer Disease / physiopathology*
Antipsychotic Agents / therapeutic use*
Drug Discovery*
Drug Industry
Humans
Interinstitutional Relations
Substances
Antipsychotic Agents